These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 34178136

  • 1. Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway.
    Weng J, Wang X, Xu B, Li W.
    Exp Ther Med; 2021 Aug; 22(2):863. PubMed ID: 34178136
    [Abstract] [Full Text] [Related]

  • 2. Alleviation of Ischemia-Reperfusion Injury in Liver Steatosis by Augmenter of Liver Regeneration Is Attributed to Antioxidation and Preservation of Mitochondria.
    Weng J, Li W, Jia X, An W.
    Transplantation; 2017 Oct; 101(10):2340-2348. PubMed ID: 28704337
    [Abstract] [Full Text] [Related]

  • 3. Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.
    Yang H, Zhou H, Zhuang L, Auwerx J, Schoonjans K, Wang X, Feng C, Lu L.
    Liver Transpl; 2017 Jan; 23(1):63-74. PubMed ID: 27597295
    [Abstract] [Full Text] [Related]

  • 4. Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway.
    Wang H, Li ZY, Wu HS, Wang Y, Jiang CF, Zheng QC, Zhang JX.
    Chin Med J (Engl); 2007 Mar 20; 120(6):509-14. PubMed ID: 17439747
    [Abstract] [Full Text] [Related]

  • 5. Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo.
    He D, Guo Z, Pu JL, Zheng DF, Wei XF, Liu R, Tang CY, Wu ZJ.
    Int Immunopharmacol; 2016 Jun 20; 35():201-209. PubMed ID: 27064547
    [Abstract] [Full Text] [Related]

  • 6. Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia/reperfusion injury.
    Kong WN, Li W, Bai C, Dong Y, Wu Y, An W.
    Am J Transplant; 2022 Jan 20; 22(1):130-143. PubMed ID: 34242470
    [Abstract] [Full Text] [Related]

  • 7. Augmenter of liver regeneration attenuates inflammatory response in the postischemic mouse liver in vivo.
    Khandoga A, Mende K, Iskandarov E, Rosentreter D, Schelcher C, Reifart J, Jauch KW, Thasler WE.
    J Surg Res; 2014 Nov 20; 192(1):187-94. PubMed ID: 24948544
    [Abstract] [Full Text] [Related]

  • 8. mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-κB pathway.
    Li Z, Zhang J, Mulholland M, Zhang W.
    FASEB J; 2017 Jul 20; 31(7):3018-3026. PubMed ID: 28356345
    [Abstract] [Full Text] [Related]

  • 9. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
    Ajamieh H, Farrell G, Wong HJ, Yu J, Chu E, Chen J, Teoh N.
    J Gastroenterol Hepatol; 2012 Aug 20; 27(8):1353-61. PubMed ID: 22432744
    [Abstract] [Full Text] [Related]

  • 10. Augmenter of liver regeneration (ALR) regulates acute pancreatitis via inhibiting HMGB1/TLR4/NF-κB signaling pathway.
    Pan LF, Yu L, Wang LM, He JT, Sun JL, Wang XB, Wang H, Bai ZH, Feng H, Pei HH.
    Am J Transl Res; 2018 Aug 20; 10(2):402-410. PubMed ID: 29511434
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury.
    Huang J, Xie P, Dong Y, An W.
    Cell Death Differ; 2021 Apr 20; 28(4):1174-1192. PubMed ID: 33110216
    [Abstract] [Full Text] [Related]

  • 12. Augmenter of liver regeneration attenuates inflammation of renal ischemia/reperfusion injury through the NF-kappa B pathway in rats.
    Yan R, Li Y, Zhang L, Xia N, Liu Q, Sun H, Guo H.
    Int Urol Nephrol; 2015 May 20; 47(5):861-8. PubMed ID: 25792007
    [Abstract] [Full Text] [Related]

  • 13. Exogenous augmenter of liver regeneration (ALR) attenuates inflammatory response in renal hypoxia re-oxygenation injury.
    Li Y, Zhang L, Liu Q, Chen GT, Sun H.
    Ren Fail; 2014 Apr 20; 36(3):432-6. PubMed ID: 24392837
    [Abstract] [Full Text] [Related]

  • 14. Augmenter of Liver Regeneration (ALR) Protects Kidney from Ischemia/Reperfusion (I/R) Injury via Regulation of TLR4/MAPK Signaling Pathway.
    Li Y, Xiong Y, Li H, Luo Y, Zhang L, Zhang Q, Xiong W, Tu H.
    J Immunol Res; 2022 Apr 20; 2022():6869730. PubMed ID: 35983075
    [Abstract] [Full Text] [Related]

  • 15. Aucubin Attenuates Liver Ischemia-Reperfusion Injury by Inhibiting the HMGB1/TLR-4/NF-κB Signaling Pathway, Oxidative Stress, and Apoptosis.
    Zhang S, Feng Z, Gao W, Duan Y, Fan G, Geng X, Wu B, Li K, Liu K, Peng C.
    Front Pharmacol; 2020 Apr 20; 11():544124. PubMed ID: 33013386
    [Abstract] [Full Text] [Related]

  • 16. Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury.
    Li TH, Liu CW, Lee PC, Huang CC, Lee KC, Hsieh YC, Yang YY, Hsieh SL, Lin HC, Tsai CY.
    J Chin Med Assoc; 2017 Jul 20; 80(7):391-400. PubMed ID: 28325574
    [Abstract] [Full Text] [Related]

  • 17. Dexmedetomidine Protects Rat Liver against Ischemia-Reperfusion Injury Partly by the α2A-Adrenoceptor Subtype and the Mechanism Is Associated with the TLR4/NF-κB Pathway.
    Wang Y, Wu S, Yu X, Zhou S, Ge M, Chi X, Cai J.
    Int J Mol Sci; 2016 Jun 23; 17(7):. PubMed ID: 27347929
    [Abstract] [Full Text] [Related]

  • 18. Liver X Receptors Activation Attenuates Ischemia Reperfusion Injury of Liver Graft in Rats.
    Cheng MX, Huang P, He Q, Chen Y, Li JZ.
    J Invest Surg; 2019 Jun 23; 32(4):298-303. PubMed ID: 29286833
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of Coriandrum sativum extract against inflammation and apoptosis in liver ischaemia/reperfusion injury.
    Kükner A, Soyler G, Toros P, Dede G, Meriçli F, Işık S, Edebal O, Özoğul C.
    Folia Morphol (Warsz); 2021 Jun 23; 80(2):363-371. PubMed ID: 32488856
    [Abstract] [Full Text] [Related]

  • 20. Ac2‑26 alleviates hepatic ischemia‑reperfusion injury based on inhibiting the positive feedback loop of HMGB1/TLR4/NF‑κB/neutrophils.
    Bai C, Jiang Z, Jiang H, Yu S, Li M, Chu F, Sheng Y, Li J, Jiang J, Li W.
    Exp Ther Med; 2022 Nov 23; 24(5):673. PubMed ID: 36237600
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.